Like to see a copy of the 1000 or so "letters", sent so far, and what it has to say to those differing agencies about MMRF patent...Docs, clinics, dentists, nurses etc.,...Eventually, their validity may be challenged IMO. A patent infringement suit not cheap at all, and time consuming, possibly yrs. Just because a patent has been issued by some examiner for all of approx. 18 or so hrs, it may still face scrutiny of being "valid".
IMO, seems like it boils down to this...MMRF has PHR, and MMRPro for sale. (maybe some cards?) So far, sales not too good, right?? They have been presented, launched, demonstrated, all over the place for quite some time, correct? Now, some patents relating somehow to the use of those products have been issued, right?? Please correct if wrong. Since those products have not made MMRF profitable, substantial revenues, to date, despite the many many demonstrations, Now, MMRF is sending letters out to hopefully get the sales/licenses/royalties, whatever, by using the patent infringement path for use of those same products that have yet to bring company success thru its past channels? Good ole fashion sales of a good product. Did I get that right???? Correct me guys, If I am wrong anywhere in this...
So many different avenues in so many PR's, I have no clue what business plan is anymore, with many ideas still coming forth from outside individuals.
From TechDirt quote
"One of the bizarre things about the patent system is the "presumption of validity," in which a patent officially has to be presumed valid. Conceptually, this makes very little sense It seems that even the US Patent Office's own data shows that's simply not true. A friend pointed me to the USPTO's recently released data concerning re-exams (pdf and embedded below), which demonstrates in great detail why patents shouldn't be presumed valid. Basically, the data suggests that an awful lot of patents were handled poorly."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.